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Alzheimer's disease is characterized by extracellular depo-
sition of beta amyloid peptide and intracellular deposi-
tion of hyperphosphorylated tau protein in isocortical
brain areas. Recently, we and others have shown that vul-
nerable neurons or tau aggregate-bearing neurons aber-
rantly express cell cycle proteins namely cdk inhibitors. In
order to analyse which factors trigger the aberrant expres-
sion of cell cycle proteins we tested whether the intracel-
lular accumulation and hyperphosphorylation of tau
protein may contribute to this response. In addition, we
wanted to know which alterations in cell cycle dynamics
are induced by tau protein overexpression in dividing
cells. Therefore, we generated SH-SY5Y neuroblastoma
cell lines stably overexpressing wildtype tau or pseudo-
phosphorylated tau mutants and analyzed their cell cycle
profile. We found that overexpression of wildtype tau lead
to an increase of cells residing in G1-phase and a reduc-
tion of cells in G2-phase compared to a vector-only
expressing cell line. However, the doubling time of the
cell lines was largely unaffected. The same profile was
observed for most of the pseudophosphorylated tau pro-
teins and was similar for three-repeat and four-repeat tau
protein. Next, using a cDNA array we looked whether
these cell cycle changes can be attributed to alterations in
gene expression in SH-SY5Y cells. We observed that tau
overexpression upregulates neuronal markers (such as L1
NCAM, muscarinic acetylcholine receptor M4), downreg-
ulates tumor markers such as several matrix metallopro-
teinases and changes expression of several cell cycle-
related genes such as CKS1, CKS2 and p21waf.
Analysis of protein levels by Western Blotting revealed an
upregulation of survivin and p27kip1 which was most
pronounced in the wildtype tau expressing cell line.
Increased MAPK activity was detected in all tau expressing
cell lines.
We showed that tau expression in neuroblastoma cells
alters gene expression, leads to an activation of MAPK sig-
nal transduction and changes the cell cycle profile. These
results suggest a link between tau accumulation and aber-
rant expression of cell cycle proteins in neurons.
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